Janus Kinase Inhibitors
Showing 1 - 25 of 6,615
Idiopathic Inflammatory Myopathies Trial in Beijing (tofacitinib)
Recruiting
- Idiopathic Inflammatory Myopathies
-
Beijing, Beijing, ChinaDepartment of Rheumatology and Immunology, Peking University Peo
Oct 9, 2022
Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in
Not yet recruiting
- Rheumatoid Arthritis
- Observation
- (no location specified)
Oct 8, 2022
Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Abrocitinib 200 MG Oral Tablet
- +2 more
- (no location specified)
Feb 21, 2023
Janus Kinase Inhibitor Therapy in Ulcerative Colitis
Terminated
- Ulcerative Colitis
- Janus Kinase Inhibitor
-
Amsterdam, North Halland, NetherlandsAmsterdam Medical Center, IBD Center
Dec 14, 2021
Alopecia Areata Trial in Sohag (Janus Kinase 1 and 2)
Recruiting
- Alopecia Areata
- Janus Kinase 1 and 2
-
Sohag, EgyptSohag University hospitals
May 12, 2023
Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)
Recruiting
- Abatacept
- +2 more
- Janus Kinase Inhibitor
- Abatacept
-
Hangzhou, Zhejiang, ChinaZhejiang Provincial People's Hospital
Jul 5, 2022
Granuloma Annulare Trial in New Haven (Abrocitinib 200 mg)
Not yet recruiting
- Granuloma Annulare
- Abrocitinib 200 mg
-
New Haven, ConnecticutYale University
Dec 19, 2022
Chronic Kidney Diseases Trial in Durham (Baricitinib, Placebo)
Recruiting
- Chronic Kidney Diseases
- Baricitinib
- Placebo
-
Durham, North CarolinaDuke Research at Pickett Road
Dec 15, 2022
Sjogren's Syndrome Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (tofacitinib, Placebo)
Recruiting
- Sjogren's Syndrome
- tofacitinib
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 24, 2022
Sarcoidosis Trial in New Haven (Abrocitinib 200 mg)
Not yet recruiting
- Sarcoidosis
- Abrocitinib 200 mg
-
New Haven, ConnecticutYale University
Jan 24, 2023
COVID-19 Trial in Halifax (Baricitinib (janus kinase inhibitor), Remdesivir (antiviral) + barictinib (janus kinase inhibitor),
Recruiting
- COVID-19
- Baricitinib (janus kinase inhibitor)
- +3 more
-
Halifax, Nova Scotia, CanadaNova Scotia Health Authority
Mar 9, 2022
Cancer Trial in Changsha (Protein Kinase Inhibitor)
Recruiting
- Cancer
- Protein Kinase Inhibitor
-
Changsha, Hunan, ChinaCentral South University
Jun 23, 2022
Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)
Not yet recruiting
- Tyrosine Kinase Inhibitors
- Chronic Myeloid Leukemia
- treatment of TKI in CML
-
Poitiers, FranceChu Poitiers
Feb 21, 2023
Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in
Recruiting
- Breast Cancer
- CT scans
- DEXA scan
-
Bronx, New YorkMontefiore Medical Center
Jan 6, 2023
Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality
Recruiting
- Breast Cancer Stage IV
- comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
-
Mansoura, Dakahlia, EgyptOncology center mansoura university
Jan 1, 2023
Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in
Not yet recruiting
- Liver Transplant; Complications
- +3 more
- multi-kinase inhibitors in combination with bevacizumab
-
Beijing, Beijing, ChinaChinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
B-cell Malignancies Undergoing Treatment With Bruton Tyrosine
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 22, 2023
Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic
Recruiting
- Atrial Fibrillation
- +4 more
- Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
-
New Hyde Park, New YorkNorthwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022
Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
Active, not recruiting
- Patients Diagnosed as Chronic Meyloid Leukemia
- Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
-
Assiut, EgyptAssiut University Hospital
Feb 19, 2022
Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)
Recruiting
- Non Small Cell Lung Cancer
- Metformin Hydrochloride
- Placebo
-
Mexico City, MexicoInstituto Nacional de Cancerologia
Jul 21, 2022
r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase
Not yet recruiting
- B-cell Lymphoma
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Aug 9, 2022
Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Rotterdam, NetherlandsErasmus MC
Feb 2, 2022
Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)
Recruiting
- Olverembatinib
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital
Jul 26, 2022